Article Text

Download PDFPDF
Sphincterotomy with FCSEMS (SPHINX): a monumental answer or the beginning of new mysteries?
  1. Mohan Ramchandani1,
  2. Aniruddha Pratap Singh1,
  3. Rupjyoti Talukdar1,
  4. D Nageshwar Reddy2
  1. 1Medical Gastroenterology, AIG Hospitals, Hyderabad, Telangana, India
  2. 2Chairman & Chief of Gastroenterology, AIG Hospitals, Hyderabad, Telangana, India
  1. Correspondence to Dr Mohan Ramchandani; ramchandanimohan{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with interest the recently published randomised controlled trial (RCT) ‘SPHINX’,1 addressing the role of endoscopic sphincterotomy (ES) with fully covered s metal stent (FCSEMS) placement in preventing post-ERCP pancreatitis (PEP). Although this is the largest RCT on the topic, several concerns warrant discussion.

Published data report variable rates of PEP after SEMS ranging from 0% to 26.8%,2–4 with lot of heterogeneity regarding the PEP preventive measures. Nevertheless severe pancreatitis remains rare. To assess the impact of ES a larger sample size will be required.

The SPHINX trial sample …

View Full Text

Footnotes

  • X @AniruddhaGI

  • Contributors The idea for the article: Dr DNR and Dr MR. Literature search: Dr MR, Dr APS and Dr RT. Writing of the Article: Dr MR, Dr APS and Dr RT. Guarantor: Dr MR (Director, Interventional Endoscopy).

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.